Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126891321 | 12689132 | 1 | I | 20160817 | 20160826 | 20160826 | EXP | CA-AMGEN-CANSP2016108429 | AMGEN | 34.00 | YR | A | M | Y | 0.00000 | 20160826 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126891321 | 12689132 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 103795 | UNKNOWN FORMULATION | ||||||||
| 126891321 | 12689132 | 2 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 126891321 | 12689132 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 126891321 | 12689132 | 4 | SS | IMURAN | AZATHIOPRINE | 1 | Unknown | UNK | 0 | ||||||||||
| 126891321 | 12689132 | 5 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | UNK | 0 | ||||||||||
| 126891321 | 12689132 | 6 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | 200 MG, BID | 0 | 200 | MG | BID | |||||||
| 126891321 | 12689132 | 7 | SS | REMICADE | INFLIXIMAB | 1 | Unknown | 0 | |||||||||||
| 126891321 | 12689132 | 8 | SS | STELARA | USTEKINUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 126891321 | 12689132 | 9 | SS | TOCILIZUMAB | TOCILIZUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 126891321 | 12689132 | 10 | SS | ULTRAVATE | HALOBETASOL PROPIONATE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126891321 | 12689132 | 1 | Product used for unknown indication |
| 126891321 | 12689132 | 2 | Product used for unknown indication |
| 126891321 | 12689132 | 3 | Product used for unknown indication |
| 126891321 | 12689132 | 4 | Product used for unknown indication |
| 126891321 | 12689132 | 5 | Product used for unknown indication |
| 126891321 | 12689132 | 6 | Psoriasis |
| 126891321 | 12689132 | 7 | Product used for unknown indication |
| 126891321 | 12689132 | 8 | Product used for unknown indication |
| 126891321 | 12689132 | 9 | Product used for unknown indication |
| 126891321 | 12689132 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126891321 | 12689132 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126891321 | 12689132 | Drug eruption | |
| 126891321 | 12689132 | Drug ineffective | |
| 126891321 | 12689132 | Epistaxis | |
| 126891321 | 12689132 | Hepatic function abnormal | |
| 126891321 | 12689132 | Hypersensitivity | |
| 126891321 | 12689132 | Muscle spasms | |
| 126891321 | 12689132 | Pain in extremity | |
| 126891321 | 12689132 | Pneumonia | |
| 126891321 | 12689132 | Stomatitis | |
| 126891321 | 12689132 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |